ContraFect Corp expected to post a loss of $10.83 a share - Earnings Preview
* ContraFect Corp CFRX.OQ CFRX.O is expected to show no
change
in quarterly revenue when it reports results on May 15
(estimated).
*
* Refinitiv's mean analyst estimate for ContraFect Corp is
for a
loss of $10.83 per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for ContraFect
Corp
is $7, above its last closing price of $1.61.
This summary was machine generated May 12 at 17:59 GMT. All
figures in US dollars unless otherwise stated
Recent news on CONTRAFECT
See all newsBrief: Contrafect Corp - On Nov 7, Co Received Delisting Notification From Nasdaq Hearings Advisor Stating That Panel Determined To Delist Co's Common Stock
Brief: ContraFect Says Selling Securityholder May Offer And Selling Up To 7 Mln Shares In Aggregate Of Common Stock
Brief: Contrafect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study
Brief: Contrafect Corp Says On Sept 21, Notified By Nasdaq, That Co Not In Compliance With The Minimum Bid Price Requirement
Brief: Contrafect Announces Submission Of Ind Application To The FDA For Its Development Candidate Cf-370